• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Erectile Dysfunction in Cirrhosis: Its Prevalence and Risk Factors.肝硬化中的勃起功能障碍:患病率及危险因素
J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1264-1275. doi: 10.1016/j.jceh.2022.05.001. Epub 2022 May 10.
2
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial.他达拉非改善肝硬化男性的勃起功能障碍及生活质量:一项随机双盲安慰剂对照试验。
Hepatol Int. 2023 Apr;17(2):434-451. doi: 10.1007/s12072-021-10264-w. Epub 2021 Nov 14.
3
Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.他达拉非,一种磷酸二酯酶-5抑制剂,可改善肝硬化患者的勃起功能障碍。
J Clin Exp Hepatol. 2019 May-Jun;9(3):312-317. doi: 10.1016/j.jceh.2018.07.007. Epub 2018 Aug 18.
4
Prevalence of and Factors Associated with Sleep-Wake Abnormalities in Patients with Cirrhosis.肝硬化患者睡眠-觉醒异常的患病率及相关因素
J Clin Exp Hepatol. 2021 Jul-Aug;11(4):453-465. doi: 10.1016/j.jceh.2020.10.006. Epub 2020 Oct 24.
5
Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.肝硬化患者轻微肝性脑病的患病率及相关因素
J Clin Exp Hepatol. 2018 Jun;8(2):156-161. doi: 10.1016/j.jceh.2017.06.005. Epub 2017 Jun 20.
6
Does Treatment of Erectile Dysfunction With PDE 5 Inhibitor Tadalafil Improve Quality of Life in Male Patients With Compensated Chronic Liver Disease? A Prospective Pilot Study.使用磷酸二酯酶 5 抑制剂他达拉非治疗勃起功能障碍能否改善代偿期慢性肝病男性患者的生活质量?一项前瞻性试点研究。
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1083-1090. doi: 10.1016/j.jceh.2022.01.009. Epub 2022 Jan 23.
7
Prevalence and associated factors of erectile dysfunction, psychological disorders, and sexual performance in primary vs. secondary infertility men.原发性不育与继发性不育男性勃起功能障碍、心理障碍和性功能的流行情况及其相关因素。
Reprod Biol Endocrinol. 2021 Mar 9;19(1):43. doi: 10.1186/s12958-021-00720-5.
8
Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes.2 型糖尿病男性中,睾丸激素缺乏症和严重的勃起功能障碍与生活质量下降独立相关。
Andrology. 2014 Mar;2(2):205-211. doi: 10.1111/j.2047-2927.2013.00177.x.
9
The effect of erectile dysfunction on quality of life in male kidney transplant recipients.勃起功能障碍对男性肾移植受者生活质量的影响。
Pak J Med Sci. 2014 Mar;30(2):361-5.
10
The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression.勃起功能障碍对接受血液透析男性生活质量的影响及其与抑郁的关系。
J Sex Med. 2010 Dec;7(12):4003-10. doi: 10.1111/j.1743-6109.2010.01993.x. Epub 2010 Aug 30.

引用本文的文献

1
Depression and anxiety management in cirrhosis.肝硬化患者抑郁和焦虑的管理
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000600. eCollection 2025 Jan 1.
2
Prevalence and risk factors of erectile dysfunction in cirrhotic patients: An observational study.肝硬化患者勃起功能障碍的患病率及危险因素:一项观察性研究。
Arab J Urol. 2023 Jul 24;22(1):6-12. doi: 10.1080/2090598X.2023.2238933. eCollection 2024.
3
Sexual dysfunctions and their treatment in liver diseases.肝脏疾病中的性功能障碍及其治疗
World J Hepatol. 2022 Aug 27;14(8):1530-1540. doi: 10.4254/wjh.v14.i8.1530.

本文引用的文献

1
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial.他达拉非改善肝硬化男性的勃起功能障碍及生活质量:一项随机双盲安慰剂对照试验。
Hepatol Int. 2023 Apr;17(2):434-451. doi: 10.1007/s12072-021-10264-w. Epub 2021 Nov 14.
2
Measuring Smoking Prevalence in a Middle Income Nation: An Examination of the 100 Cigarettes Lifetime Screen.衡量一个中等收入国家的吸烟流行率:对终生吸食100支香烟筛查的考察
Glob Epidemiol. 2019 Nov;1. doi: 10.1016/j.gloepi.2019.100016. Epub 2019 Oct 26.
3
Sarcopenia is associated with severe erectile dysfunction in older adults: a population-based cohort study.骨骼肌减少症与老年人严重勃起功能障碍相关:一项基于人群的队列研究。
Korean J Intern Med. 2020 Sep;35(5):1245-1253. doi: 10.3904/kjim.2019.148. Epub 2020 Apr 21.
4
Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.他达拉非,一种磷酸二酯酶-5抑制剂,可改善肝硬化患者的勃起功能障碍。
J Clin Exp Hepatol. 2019 May-Jun;9(3):312-317. doi: 10.1016/j.jceh.2018.07.007. Epub 2018 Aug 18.
5
Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients.神经认知障碍与肝硬化患者的勃起功能障碍有关。
Dig Liver Dis. 2019 Jun;51(6):850-855. doi: 10.1016/j.dld.2019.03.030. Epub 2019 Apr 25.
6
Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management.肝硬化患者的性功能障碍和性激素异常:发病机制和治疗的综述。
Hepatology. 2019 Jun;69(6):2683-2695. doi: 10.1002/hep.30359. Epub 2019 May 14.
7
Erectile dysfunction in compensated liver cirrhosis.代偿期肝硬化患者的勃起功能障碍
Dig Liver Dis. 2019 Jun;51(6):843-849. doi: 10.1016/j.dld.2018.10.015. Epub 2018 Oct 29.
8
Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.终末期肝病患者的症状患病率和生活质量:系统评价和荟萃分析。
Palliat Med. 2019 Jan;33(1):24-36. doi: 10.1177/0269216318807051. Epub 2018 Oct 22.
9
EASL Clinical Practice Guidelines on nutrition in chronic liver disease.EASL 临床实践指南:慢性肝病中的营养问题。
J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.
10
Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis.勃起功能障碍与抑郁:系统评价与荟萃分析。
J Sex Med. 2018 Aug;15(8):1073-1082. doi: 10.1016/j.jsxm.2018.05.016. Epub 2018 Jun 28.

肝硬化中的勃起功能障碍:患病率及危险因素

Erectile Dysfunction in Cirrhosis: Its Prevalence and Risk Factors.

作者信息

Jagdish Rakesh K, Kamaal Ahmed, Shasthry Saggere M, Benjamin Jaya, Maiwall Rakhi, Jindal Ankur, Choudhary Ashok, Rajan Vijayaraghavan, Arora Vinod, Bhardwaj Ankit, Kumar Guresh, Kumar Manoj, Sarin Shiv K

机构信息

Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India.

Department of Urology, Institute of Liver and Biliary Sciences, New Delhi, India.

出版信息

J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1264-1275. doi: 10.1016/j.jceh.2022.05.001. Epub 2022 May 10.

DOI:10.1016/j.jceh.2022.05.001
PMID:36157150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9499842/
Abstract

BACKGROUND

Erectile dysfunction (ED) is common in men with cirrhosis. The aim of this study was to assess the prevalence of ED and the factors associated with ED in men with cirrhosis.

METHODS

400 men with cirrhosis [Child-Turcotte-Pugh (CTP) class A, 44.0%; CTP class B, 41.0%; and CTP class C, 15.0%] having high Karnofsky performance score, and living in a stable monogamous relationship with a female partner were included in the study. International Index of Erectile Function (IIEF) questionnaire, and Short-Form (36) Health Survey (SF-36) were used to assess erectile function and the health-related quality of life (HRQOL), respectively.

RESULTS

ED was found in 289 (72.3%) patients. Patients with ED reported significantly lower SF-36 scores across all the eight domains of SF-36 (i.e., physical functioning score, role physical score, bodily pain score, general health perception score, vitality score, social functioning score, role emotional score, and mental health score); physical component summary score, and mental physical component summary score, compared with those without ED. On multivariate analysis, factors associated with ED were older age, longer duration of cirrhosis, CTP-C (vs. CTP-A), higher hepatic venous pressure gradient (HVPG), presence of generalized anxiety disorder (GAD), presence of major depression, and lower appendicular skeletal muscle index measured by dual-energy X-ray absorptiometry (DEXA ASMI).

CONCLUSION

ED is common in men with cirrhosis, and men with ED have poor HRQOL compared with those without ED. Older age, longer duration of cirrhosis, CTP-C (vs. CTP-A), higher HVPG, presence of GAD, presence of major depression, and lower DEXA ASMI are associated with ED.

摘要

背景

勃起功能障碍(ED)在肝硬化男性中很常见。本研究的目的是评估肝硬化男性中ED的患病率以及与ED相关的因素。

方法

本研究纳入了400例肝硬化男性患者[Child-Turcotte-Pugh(CTP)分级:A级占44.0%;B级占41.0%;C级占15.0%],这些患者卡氏功能状态评分较高,且与女性伴侣保持稳定的一夫一妻制关系。分别使用国际勃起功能指数(IIEF)问卷和简明健康调查(SF-36)来评估勃起功能和健康相关生活质量(HRQOL)。

结果

289例(72.3%)患者存在ED。与无ED的患者相比,ED患者在SF-36的所有八个领域(即身体功能评分、角色身体评分、身体疼痛评分、总体健康感知评分、活力评分、社会功能评分、角色情感评分和心理健康评分)、身体成分汇总评分和精神身体成分汇总评分上均显著较低。多因素分析显示,与ED相关的因素包括年龄较大、肝硬化病程较长、CTP-C级(与CTP-A级相比)、肝静脉压力梯度(HVPG)较高、存在广泛性焦虑障碍(GAD)、存在重度抑郁症以及通过双能X线吸收法(DEXA)测量的四肢骨骼肌指数较低。

结论

ED在肝硬化男性中很常见,与无ED的男性相比,有ED的男性HRQOL较差。年龄较大、肝硬化病程较长、CTP-C级(与CTP-A级相比)、HVPG较高、存在GAD、存在重度抑郁症以及DEXA测量的四肢骨骼肌指数较低与ED相关。